Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome
2006
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
2012 StandoutScience
Molecular basis of MAPK-activated protein kinase 2:p38 assembly
2007
The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type
2012
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Molecular Cloning and Characterization of a P38-Like Mitogen-Activated Protein Kinase from Echinococcus granulosus
2016
PROGNOSTIC FACTORS IN MULTIPLE MYELOMA
1999
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
2015 Standout
Prognostic value of nuclear grade of renal cell carcinoma
1995
Type I interferons in Sjögren's syndrome
2012
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Pre-metastatic niches: organ-specific homes for metastases
2017
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL–RANK signaling system
2005
Role of AID in Tumorigenesis
2007 StandoutNobel
Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity
2006
Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases
2008
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo
2004 StandoutNobel
Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
2005
Gout
2009 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Osteoporosis: now and the future
2011 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Skeletal remodeling in health and disease
2007 Standout
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
2011 Standout
Work above shoulder level and degenerative alterations of the rotator cuff tendons: A magnetic resonance imaging study
2004
PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase‐3β in osteoblastic Saos‐2 cells
2007 StandoutNobel
Local Anesthetics Induce Apoptosis in Human Thyroid Cancer Cells through the Mitogen-Activated Protein Kinase Pathway
2014
Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
2005
NF-κB and IKK as therapeutic targets in cancer
2006 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
OPG, RANKL, and RANK in Cancer Metastasis: Expression and Regulation
2004
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
2008 Standout
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
2006
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Cholinergic innervation and function in the prostate gland
2002
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
2011
The osteopontin transgenic mouse is a new model for Sjögren's syndrome
2015
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
2010
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Associations between work-related factors and specific disorders of the shoulder – a systematic review of the literature
2010 Standout
Neoplastic development in plasma cells
2003
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Exosomes
2019 Standout
Inflammatory and immune pathways in the pathogenesis of periodontal disease
2013 Standout
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2004
Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
2003
Echinococcosis: Advances in the 21st Century
2019 Standout
Tophaceous Gout of the Spine Mimicking Epidural Infection: Case Report and Review of the Literature
2001
Gout
2021 Standout
Plasmablastic Morphology—An Independent Prognostic Factor With Clinical and Laboratory Correlates: Eastern Cooperative Oncology Group (ECOG) Myeloma Trial E9486 Report by the ECOG Myeloma Laboratory Group
1998
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2005
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Gout in the Spine: Imaging, Diagnosis, and Outcomes
2015
Works of J Quillard being referenced
Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome
2004
RANK (receptor activator of nuclear factor‐κB) and RANKL expression in multiple myeloma
2002
High‐level expression, activation, and subcellular localization of p38‐MAP kinase in thyroid neoplasms
2006
Enhanced expression of interleukin-6 in bone and serum of metastatic renal cell carcinoma
1998
Tendon of the normal supraspinatus muscle: correlations between MR imaging and histology
1995
Anatomy of the prostatic nerves
1994
Expression, Hormonal Regulation, and Subcellular Localization of CCAAT/Enhancer-Binding Protein-β in Rat and Human Thyrocytes
2005
Prognostic significance of plasma cell morphology in multiple myeloma.
1988
Spinal tophaceous gout.
1998
Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
1989
[Heterogenicity of the response to chemotherapy in plasmablastic myeloma].
1987
[Quantification of nucleolar organizers (NORs) in renal carcinomas. Comparison with the nuclear grade].
1992